A smartphone app designed to identify potential mistakes in medications for patients with chronic kidney disease (CKD) led to a 60% relative reduction in the incidence of discrepancies
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KOMBIGLYZE® XR Saxagliptin/metformin hydrochloride modified release Consumer Medicine Information What is in this leaflet This
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NATRILIX CMI indapamide (pronounced ind-ap-a-mide) CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DIABEX* XR contains the active ingredient metformin hydrochloride CONSUMER MEDICINE INFORMATION What is in this
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KYPROLIS® Carfilzomib (kar FILZ oh mib) Consumer Medicine Information (CMI) What is in this leaflet
Chronic kidney disease (CKD) refers to the lasting damage to the kidneys, which can lead to kidney failure or end-stage renal disease (ESRD) for which you need kidney
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
